189 related articles for article (PubMed ID: 19533181)
21. CT-Guided Percutaneous Spine Biopsy in Suspected Infection or Malignancy: A Study of 214 Patients.
Rehm J; Veith S; Akbar M; Kauczor HU; Weber MA
Rofo; 2016 Dec; 188(12):1156-1162. PubMed ID: 27907940
[No Abstract] [Full Text] [Related]
22. Role of
Budak E; Yanarateş A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):14-19. PubMed ID: 31744788
[TBL] [Abstract][Full Text] [Related]
23. Computed tomography-guided biopsy of the spine. A review of 103 patients.
Kornblum MB; Wesolowski DP; Fischgrund JS; Herkowitz HN
Spine (Phila Pa 1976); 1998 Jan; 23(1):81-5. PubMed ID: 9460157
[TBL] [Abstract][Full Text] [Related]
24. CT-guided biopsy of sacral metastatic carcinoma not visible on CT scan.
Coombs RJ; Denman LH; Ebraheim NA; Conover SR
Spine (Phila Pa 1976); 1988 May; 13(5):588-9. PubMed ID: 3187704
[No Abstract] [Full Text] [Related]
25. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
26. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
27. Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin.
Ben-Baruch S; Canaani J; Braunstein R; Perry C; Ben-Ezra J; Polliack A; Naparstek E; Herishanu Y
Mayo Clin Proc; 2012 Feb; 87(2):136-42. PubMed ID: 22226833
[TBL] [Abstract][Full Text] [Related]
28. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
30. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
[TBL] [Abstract][Full Text] [Related]
32. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Paul SA; Stoeckli SJ; von Schulthess GK; Goerres GW
Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):189-95. PubMed ID: 17177026
[TBL] [Abstract][Full Text] [Related]
33. Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis.
Chen YH; Yang XM; Li SS; Wang YH; He JJ; Yang YD; Wang S; Liu JJ; Zhang XL
J Med Imaging Radiat Oncol; 2012 Feb; 56(1):66-74. PubMed ID: 22339748
[TBL] [Abstract][Full Text] [Related]
34. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
35. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
36. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
37. Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer.
Huncharek M; Muscat J
Abdom Imaging; 1996; 21(4):364-7. PubMed ID: 8661585
[TBL] [Abstract][Full Text] [Related]
38. Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma.
Sokoya M; Chowdhury F; Kadakia S; Ducic Y
Laryngoscope; 2018 Nov; 128(11):2573-2575. PubMed ID: 30194842
[TBL] [Abstract][Full Text] [Related]
39. Serum tumor markers in skeletal metastasis.
Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance.
Alle N; Tan N; Huss J; Huang J; Pantuck A; Raman SS
Abdom Radiol (NY); 2018 Jul; 43(7):1813-1819. PubMed ID: 29079986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
